Literature DB >> 21353986

Resorbable inferior vena cava filters: trial in an in-vivo porcine model.

Axel Thors1, Patrick Muck.   

Abstract

PURPOSE: To determine the feasibility, effects, and complications of a resorbable inferior vena cava (IVC) filter in a porcine model.
MATERIALS AND METHODS: Ten handmade, dual-filtration level, resorbable IVC filters were produced and gas sterilized. A dual-filtration cone was constructed using polyglycolic acid polymer strands oriented in a staggered cone formation with the apex of the cone in a cephalad orientation in relation to the IVC. IVC fixation was accomplished using a nitinol Z-stent, which was not resorbable. Operative insertion employing a paramedian incision, infrarenal vena caval dissection, venotomy, and device insertion using an 8-F rigid sheath was performed on 10 Yorkshire-type pigs (> 50 lb). Percutaneous delivery was not performed because of cost constraints. The IVC filters were operatively removed en bloc 6 weeks after implantation, and the pigs were euthanized. The IVC specimens were subsequently analyzed grossly and using light microscopy.
RESULTS: In 9 (90%) of the 10 retrieved devices, the filtration cones were completely dissolved. One device (10%) had a retained strand of filtration cone material completely incorporated into the caval wall, excluded from luminal flow. Significant inflammatory response was appreciated from the specimen histology, and significant collagen deposition was observed, especially on trichrome staining. The intima and media of 9 of 10 specimens were two to three times normal thickness. Significant reactive change was also appreciated in the pericaval lymph nodes that were taken in the specimen. One pig (10%) developed a postoperative wound infection requiring treatment.
CONCLUSIONS: Resorbable IVC filters are feasible and could be used for specific patient populations. This study outlines the need for further research of bioabsorbable polymers, absorption mechanics in the vascular system, absorption times, efficacy models, and practical application.
Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21353986     DOI: 10.1016/j.jvir.2010.11.030

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  7 in total

1.  Inferior Vena Cava Filters: Indications, Outcomes, and Evidence.

Authors:  Jennifer P Montgomery; John A Kaufman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-09

2.  Safety and Efficacy of an Absorbable Filter in the Inferior Vena Cava to Prevent Pulmonary Embolism in Swine.

Authors:  Steven Y Huang; Mitchell Eggers; Mark J McArthur; Katherine A Dixon; Amanda McWatters; Stephen Dria; Lori R Hill; Marites P Melancon; Joseph R Steele; Michael J Wallace
Journal:  Radiology       Date:  2017-07-14       Impact factor: 11.105

Review 3.  A Critical Review of Available Retrievable Inferior Vena Cava Filters and Future Directions.

Authors:  Jennifer P Montgomery; John A Kaufman
Journal:  Semin Intervent Radiol       Date:  2016-06       Impact factor: 1.513

4.  Randomized Controlled Study of an Absorbable Vena Cava Filter in a Porcine Model.

Authors:  Mitchell Eggers; Serge Rousselle; Mark Urtz; Rhonda Albright; Alice Will; Bettina Jourden; Cynthia Godshalk; Stephen Dria; Steven Huang; Joseph Steele
Journal:  J Vasc Interv Radiol       Date:  2019-06-13       Impact factor: 3.464

5.  Magnetic resonance imaging evaluation of Yukatan minipig brains for neurotherapy applications.

Authors:  Seung Pil Yun; Dong Hyun Kim; Jung Min Ryu; Jae Hong Park; Su Shin Park; Ji Hoon Jeon; Bit Na Seo; Hyun-Jeong Kim; Jun-Gyu Park; Kyoung-Oh Cho; Ho Jae Han
Journal:  Lab Anim Res       Date:  2011-12-19

6.  Infusion of iodine-based contrast agents into poly(p-dioxanone) as a radiopaque resorbable IVC filter.

Authors:  Burapol Singhana; Aaron Chen; Patrick Slattery; Iman K Yazdi; Yang Qiao; Ennio Tasciotti; Michael Wallace; Steven Huang; Mitch Eggers; Marites P Melancon
Journal:  J Mater Sci Mater Med       Date:  2015-02-18       Impact factor: 3.896

7.  [Vena cava filter. Which indications remain in the era of differentiated anticoagulation?].

Authors:  A H Mahnken
Journal:  Radiologe       Date:  2013-03       Impact factor: 0.635

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.